6. パーキンソン病 Parkinson disease Clinical trials / Disease details


臨床試験数 : 2,307 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

  
3 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04706065
(ClinicalTrials.gov)
January 31, 20213/1/2021SHMT1 Polymorphism in Parkinson's Disease,Genetic Polymorphisms of Serine Hydroxylmethyl Transferase 1 (SHMT1) in Patients With Parkinson's DiseaseStudy the Role of SHMT1 Polymorphism in Parkinson DiseaseGenetic: SHMT1 polymorphismAssiut UniversityAswan University HospitalRecruiting50 YearsN/AAll80Egypt
2NCT02579473
(ClinicalTrials.gov)
January 201613/10/2015A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214A Multi-center, Open-label, Multiple Ascending Dosage-ranging Cohort (MAD) Study in Early, Untreated or Stably Treated Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetics (PK) of Injections of SER-214 Administered Subcutaneously Once a Week for Two Weeks After 0-2 Weeks of Dose TitrationParkinson's DiseaseDrug: SER-214Serina TherapeuticsNULLActive, not recruiting40 Years80 YearsAll20Phase 1United States
3NCT00215904
(ClinicalTrials.gov)
August 200318/9/2005D-serine Adjuvant Treatment for Parkinson's DiseaseD-serine Adjuvant Treatment for Parkinson's DiseaseParkinson's DiseaseDrug: D-serine (~2g/day)Herzog HospitalNULLCompleted30 Years75 YearsBoth13Phase 4Israel